Cite
HARVARD Citation
Lesuisse, D. et al. (2019). Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease. Bioorganic & medicinal chemistry letters. 29 (7), pp. 929-932. [Online].